Verition Fund Management LLC - INOTEK PHARMACEUTICALS CORP ownership

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of INOTEK PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2019$8,010,000
+9.4%
7,300,0000.0%0.15%
-27.7%
Q3 2019$7,319,000
-0.9%
7,300,0000.0%0.20%
-2.9%
Q2 2019$7,389,000
+9.1%
7,300,000
+8.5%
0.21%
-21.2%
Q1 2019$6,773,000
+104.4%
6,727,000
+94.8%
0.26%
+10.9%
Q4 2018$3,314,000
+81.5%
3,453,000
+111.5%
0.24%
+266.2%
Q3 2018$1,826,000
+21.2%
1,633,000
+10.9%
0.06%
-29.3%
Q2 2018$1,506,000
+119.5%
1,473,000
+107.8%
0.09%
+80.4%
Q1 2018$686,000709,0000.05%
Other shareholders

There were no reported owners of INOTEK PHARMACEUTICALS CORP in Q3 2023.

NameSharesValueWeighting ↓
View complete list of INOTEK PHARMACEUTICALS CORP shareholders